1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. PPAR
  4. PPAR Inhibitors

PPAR Inhibitors

PPARα

PPARβ/δ

PPARγ

PPAR

PPARδ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PPAR Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name PPARα PPARβ/δ PPARγ PPAR PPARδ Purity
Retinoic acid
PPARα, Kd: 103 nM
PPARβ/δ, Kd: 17 nM
PPARγ, Kd: 178 nM
    99.74%
Rosiglitazone    
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    99.90%
GW9662
PPARα, IC50: 32 nM
PPARδ, IC50: 2000 nM
PPARγ, IC50: 3.3 nM
    99.83%
GW6471
PPARα
        98.81%
Pioglitazone
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
hPPARγ, EC50: 0.93 μM
mouse PPARγ, EC50: 0.99 μM
    ≥98.0%
FK614    
PPAR-γ
    99.82%
AMG131    
PPARγ
    99.13%
Fenofibrate
PPARα, IC50: 30 μM
        ≥98.0%
T0070907
PPARα, Ki: 0.85 μM
PPARδ, Ki: 1.8 μM
PPARγ, Ki: 1 nM
    99.98%
Troglitazone    
PPARγ, EC50: 550 nM (Human PPARγ)
    98.60%
Pirinixic acid
PPARα, EC50: 0.63 μM
 
PPARγ, EC50: 32 μM
    99.80%
GW 501516  
PPARδ, EC50: 1.1 nM
      99.15%
Elafibranor
PPAR-α, EC50: 45 nM
PPAR-δ, EC50: 175 nM
      99.18%
5-Aminosalicylic Acid    
PPARγ
    ≥98.0%
GW1929    
PPAR-γ, pEC50: 8.56 (Human PPAR-γ)
    99.77%
Daidzein
PPAR-α
 
PPAR-γ
    ≥98.0%
Lanifibranor
PPARα, EC50: 1537 nM (Human PPARα)
PPARδ, EC50: 866 nM (Human PPARδ)
PPARγ, EC50: 206 nM (Human PPARγ)
    99.56%
GW7647
PPARα, EC50: 6 nM (Human PPARα)
PPARδ, EC50: 6.2 μM (Human PPARδ)
PPARγ, EC50: 1.1 μM (Human PPARγ)
    ≥98.0%
Icariin
PPARα
        ≥98.0%
GW0742
PPARα, EC50: 1.1 μM
PPARδ, EC50: 1 nM
PPARγ, EC50: 2 μM
    99.47%
Astaxanthin    
PPARγ
    ≥98.0%
Bezafibrate
hPPARα, EC50: 50 μM
hPPARδ, EC50: 20 μM
hPPARγ, EC50: 60 μM
    ≥98.0%
GSK3787  
PPARδ, pIC50: 6.6 nM
      99.04%
FH535      
PPAR
  99.87%
CDDO-Im
PPARα, Ki: 232 nM
 
PPARγ, Ki: 344 nM
    98.19%
Rosiglitazone maleate    
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    99.75%
Gemfibrozil
PPAR-α
        99.91%
Magnolol    
PPARγ, EC50: 17.7 μM
    99.92%
Eupatilin
PPARα
        99.01%
Glabridin    
PPARγ, EC50: 6.1 μM
    99.98%
Pioglitazone hydrochloride
PPARα, EC50: 0.93 μM (Human PPARα)
PPARδ, EC50: 0.01 μM (Human PPARδ)
PPARγ, EC50: 43 μM (Human PPARγ)
    99.75%
Palmitelaidic Acid
PPARα
        ≥99.0%
Clofibrate
PPARα, EC50: 50 μM
 
PPARγ, EC50: 500 μM
    99.61%
Fenofibric acid
PPARα, EC50: 22.4 μM
PPARδ, EC50: 1.06 μM
PPARγ, EC50: 1.47 μM
    ≥98.0%
Seladelpar sodium salt  
PPAR-δ, EC50: 2 nM
      98.39%
Alpinetin    
PPAR-γ
    99.07%
NXT629
hPPARα, IC50: 77 nM
hPPARδ, IC50: 6 μM
hPPARγ, IC50: 15 μM
    99.20%
L-165041  
PPARδ, Ki: 6 nM
PPARγ, Ki: 730 nM
    99.74%
Indeglitazar
PPARα
PPARδ
PPARγ
    99.59%
Saroglitazar Magnesium
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
    98.85%
Balaglitazone    
PPARγ, EC50: 351 nM (Human PPARγ)
    99.97%
Saroglitazar
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
    98.03%
Oleuropein    
PPARγ
    98.54%
Oleoylethanolamide
PPAR-α
        ≥98.0%
Mifobate    
PPARγ, IC50: 140 μM
    ≥99.0%
Ginsenoside Rh1    
PPAR-γ
    ≥98.0%
Inolitazone dihydrochloride    
PPARγ
    98.36%
EHP-101    
PPARγ
    98.56%
Raspberry ketone
PPAR-α
        99.93%
Aleglitazar
PPARα, IC50: 38 nM
 
PPARγ, IC50: 19 nM
    99.30%
Adelmidrol    
PPARγ
    ≥98.0%
DG172 dihydrochloride  
PPARβ/δ, IC50: 27 nM
      99.03%
Oroxin A    
PPARγ
    99.80%
Gypenoside XLIX
PPAR-α
        ≥99.0%
Agrimol B    
PPARγ
    99.75%
Ciprofibrate
PPARα
        99.79%
BMS-687453
PPARα, IC50: 260 nM (Human PPARα)
        99.04%
Ophiopogonin D
PPARα
        98.59%
Cefminox sodium    
PPARγ
    99.83%
MA-0204  
PPARδ, EC50: 0.4 nM (in human)
PPARδ, EC50: 7.9 nM (in mouse)
PPARδ, EC50: 10 nM (in rat)
      99.71%
15-Deoxy-Δ-12,14-prostaglandin J2    
PPARγ, EC50: 2 μM
    ≥96.0%
Methyl oleanonate    
PPARγ
    99.49%
Bilobetin
PPARα
        98.30%
Licarin B    
PPARγ
    99.71%
4-O-Methyl honokiol    
PPARγ
    99.65%
Seladelpar
PPAR-α, EC50: 1600 nM
PPAR-δ, EC50: 2 nM
     
CP-868388 free base
hPPARα, Ki: 10.8 nM
 
hPPARγ, Ki: 3.47 μM
    99.66%
GSK376501A    
PPARγ
    99.06%
CUDA
PPARα
        ≥98.0%
PPAR agonist 1
PPARα
 
PPARγ
    96.86%
Rosiglitazone hydrochloride    
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
   
HWL-088  
PPARδ, EC50: 570.9 nM
      98.80%
Pparδ agonist 5        
PPARδ, EC50: 0.335 μM
Glabrone    
PPAR-γ
   
Ciprofibrate impurity A
PPARα
       
LJ570
PPARα, EC50: 1.05 μM
 
PPARγ, EC50: 0.12 μM
   
Caulophyllogenin    
PPARγ, EC50: 12.6 μM
   
Pparδ agonist 1  
PPARδ, EC50: 5.06 nM
     
Darglitazone    
PPAR-γ
   
Angeloylgomisin H    
PPAR-γ
   
Fonadelpar  
PPARδ
     
Chiglitazar
PPARα, EC50: 1.8 μM
PPARδ, EC50: 1.7 μM
PPARγ, EC50: 0.08 μM
   
Edaglitazone
PPARα, EC50: 1053 nM
 
PPARγ, EC50: 35.6 nM
   
Pparδ agonist 2  
PPARδ
     
KD-3010  
PPARδ
     
DS-6930    
PPARγ, EC50: 41 nM
   
Ertiprotafib
PPARα, EC50: ~1 μM
PPARβ, EC50: ~1 μM
     
13-Oxo-9E,11E-octadecadienoic acid
PPARα
       
SR1664    
PPAR-γ, IC50: 80 nM
   
Mesalamine impurity P      
PPAR
 
Norathyriol
PPARα, IC50: 92.8 μM
PPARβ, IC50: 102.4 μM
PPARγ, IC50: 153.5 μM
   
Falcarindiol    
PPARγ
   
Imiglitazar
PPARα, EC50: 67 nM
 
PPARγ1, EC50: 31 nM
   
Inolitazone    
PPARγ
   
AVE-8134
PPARα, EC50: 100 nM (Human PPARα)
       
Arhalofenate    
PPAR-γ
   
PPARα-MO-1
PPARα